-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QnlnBb3mmTBdzo8dyiER+mLHAtEiP7PgRPbtecX3LmA3rlSxIKBx3ywmEk8T3BZz
 KlSuWzb+Z6a6jfufJYaZiw==

<SEC-DOCUMENT>0001179110-04-016266.txt : 20040811
<SEC-HEADER>0001179110-04-016266.hdr.sgml : 20040811
<ACCEPTANCE-DATETIME>20040811140827
ACCESSION NUMBER:		0001179110-04-016266
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040809
FILED AS OF DATE:		20040811

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BOYER ANDREW S
		CENTRAL INDEX KEY:			0001239546

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13305
		FILM NUMBER:		04966635

	MAIL ADDRESS:	
		STREET 1:		C/O WATSON PHARMA INC
		STREET 2:		360 MOUNT KEMBLE AVE
		CITY:			MORRISTOWN
		STATE:			NJ
		ZIP:			07960

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WATSON PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000884629
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				953872914
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		311 BONNIE CIRCLE
		CITY:			CORONA
		STATE:			CA
		ZIP:			92880
		BUSINESS PHONE:		9092701400

	MAIL ADDRESS:	
		STREET 1:		311 BONNIE CIRCLE
		CITY:			CORONA
		STATE:			CA
		ZIP:			92880
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>FORM 4 -
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2004-08-09</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000884629</issuerCik>
        <issuerName>WATSON PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>WPI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001239546</rptOwnerCik>
            <rptOwnerName>BOYER ANDREW S</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O WATSON PHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>360 MOUNT KEMBLE AVENUE</rptOwnerStreet2>
            <rptOwnerCity>MORRISTOWN</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07960</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>VP, Sales &amp; Marketing</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.0033</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1925</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Options to Purchase Common Stock</value>
                <footnoteId id="F2"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>26.14</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-08-09</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>16000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2005-08-09</value>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2014-08-09</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.0033</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>16000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Acquired through Watson Pharmaceuticals, Inc. Employee Stock Purchase Plan.</footnote>
        <footnote id="F2">The options are to be incentive stock options to the extent permitted by law, and thereafter to be non-statutory stock options.</footnote>
        <footnote id="F3">These stock options become exercisable in five annual installments of 3,200 each commencing on August 9, 2005.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ANDREW S. BOYER</signatureName>
        <signatureDate>2004-08-10</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----